Adjuvant treatment for biliary tract tumors: lost in a maze?

Hepatology. 2023 May 1;77(5):1465-1468. doi: 10.1097/HEP.0000000000000301. Epub 2023 Jan 23.

Authors

Angela Lamarca^{1

2

3}, Julien Edeline⁴

Affiliations

¹ Department of Oncology-OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
² Department of Medical Oncology, The Christie NHS Foundation, Manchester, UK.
³ Division of Cancer Sciences, University of Manchester, Manchester, UK.
⁴ INSERM, Univ Rennes, Department of Medical Oncology, CLCC Eugène Marquis, COSS (Chemistry Oncogenesis Stress Signaling)-UMR_S 1242, Rennes, France.

PMID: 36680463
DOI: 10.1097/HEP.0000000000000301

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Editorial
Comment

MeSH terms

Biliary Tract Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Gemcitabine
Humans

Substances

Gemcitabine